Cargando…

EglN2 contributes to triple negative breast tumorigenesis by functioning as a substrate for the FBW7 tumor suppressor

EglN2 contributes to ERα-positive breast tumorigenesis by acting as an estrogen-inducible gene. However, the detailed molecular mechanism(s) underlying the post-transcriptional regulation of EglN2 and its potential role in Triple Negative Breast Cancer (TNBC) remains largely unclear. By using C3Tag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takada, Mamoru, Zhuang, Ming, Inuzuka, Hiroyuki, Zhang, Jing, Zurlo, Giada, Zhang, Jinfang, Zhang, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351669/ https://www.ncbi.nlm.nih.gov/pubmed/28036276 http://dx.doi.org/10.18632/oncotarget.14290

Ejemplares similares

EglN2 positively regulates mitochondrial function in breast cancer
por: Zhang, Jing, et al.
Publicado: (2015)

Transformation by the R Enantiomer of 2-Hydroxyglutarate Linked to EglN Activation
por: Koivunen, Peppi, et al.
Publicado: (2012)

Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase
por: Zheng, Xingnan, et al.
Publicado: (2014)

Negative regulation of DAB2IP by Akt and SCF(Fbw7) pathways
por: Dai, Xiangping, et al.
Publicado: (2014)

A mitochondrial EglN1‐AMPKα axis drives breast cancer progression by enhancing metabolic adaptation to hypoxic stress
por: Jiang, Weiwei, et al.
Publicado: (2023)

Polymorphisms in the Egl nine homolog 3 (EGLN3) and Peroxisome proliferator activated receptor-alpha (PPARα) genes and their correlation with hypoxia adaptation in Tibetan chickens
por: Zhong, ChengLin, et al.
Publicado: (2018)

Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer
por: Zurlo, Giada, et al.
Publicado: (2019)

ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer
por: Ji, Shunrong, et al.
Publicado: (2015)

Structural investigation of nucleophosmin interaction with the tumor suppressor Fbw7γ
por: Di Matteo, A, et al.
Publicado: (2017)

Fbw7 dimerization determines the specificity and robustness of substrate degradation
por: Welcker, Markus, et al.
Publicado: (2013)

EGLN1 induces tumorigenesis and radioresistance in nasopharyngeal carcinoma by promoting ubiquitination of p53 in a hydroxylase-dependent manner
por: Sun, Lu, et al.
Publicado: (2022)

Suppression of Glioma Progression by Egln3
por: Sciorra, Vicki A., et al.
Publicado: (2012)

The SCF(FBW7) ubiquitin ligase complex as a tumor suppressor in T cell leukemia
por: Thompson, Benjamin J., et al.
Publicado: (2007)

Proteasomal degradation of the tumour suppressor FBW7 requires branched ubiquitylation by TRIP12
por: Khan, Omar M., et al.
Publicado: (2021)

Two diphosphorylated degrons control c-Myc degradation by the Fbw7 tumor suppressor
por: Welcker, Markus, et al.
Publicado: (2022)

Isoform- and cell cycle–dependent substrate degradation by the Fbw7 ubiquitin ligase
por: Grim, Jonathan E., et al.
Publicado: (2008)

Fbw7/hCDC4 dimerization regulates its substrate interactions
por: Welcker, Markus, et al.
Publicado: (2007)

SCF(FBW7)-mediated degradation of Brg1 suppresses gastric cancer metastasis
por: Huang, Li-Yu, et al.
Publicado: (2018)

Dependence of Human Colorectal Cells Lacking the FBW7 Tumor Suppressor on the Spindle Assembly Checkpoint
por: Bailey, Melanie L., et al.
Publicado: (2015)

FBW7 in hematological tumors
por: Zhu, Qiaojuan, et al.
Publicado: (2020)

SCF(Fbw7) Regulates Cellular Apoptosis By Targeting Mcl-1 for Ubiquitination and Destruction
por: Inuzuka, Hiroyuki, et al.
Publicado: (2011)

Aberrant regulation of FBW7 in cancer
por: Wang, Lixia, et al.
Publicado: (2014)

SOX9 is targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA damage
por: Hong, Xuehui, et al.
Publicado: (2016)

Whole-Genome Sequencing Identifies the Egl Nine Homologue 3 (egln3/phd3) and Protein Phosphatase 1 Regulatory Inhibitor Subunit 2 (PPP1R2P1) Associated with High-Altitude Polycythemia in Tibetans at High Altitude
por: Gesang, Luobu, et al.
Publicado: (2019)

Fbw7 and Usp28 – enemies and allies
por: Taranets, Lyudmyla, et al.
Publicado: (2015)

Dysregulation of FBW7 in malignant lymphoproliferative disorders
por: Wan, Xin, et al.
Publicado: (2022)

Artists Dorota Gaweda and Egle Kulbokaite visit the CMS experiment
por: Agrigoroae, Cristina
Publicado: (2022)

The mRNA transportome of the BicD/Egl transport machinery
por: Vazquez-Pianzola, Paula, et al.
Publicado: (2016)

LRP-2 likely acts downstream of EGL-20/Wnt
por: Minor, Paul J, et al.
Publicado: (2019)

A negative feedback loop between XBP1 and Fbw7 regulates cancer development
por: Chae, Unbin, et al.
Publicado: (2019)

Variants of the Low Oxygen Sensors EGLN1 and HIF-1AN Associated with Acute Mountain Sickness
por: Zhang, Enhao, et al.
Publicado: (2014)

Roles of eIF3m in the tumorigenesis of triple negative breast cancer
por: Han, Wei, et al.
Publicado: (2020)

Congenital erythrocytosis – discover of a new mutation in the EGLN1 gene
por: Barradas, João, et al.
Publicado: (2018)

Effect of EGLN1 Genetic Polymorphisms on Hemoglobin Concentration in Andean Highlanders
por: Yasukochi, Yoshiki, et al.
Publicado: (2020)

MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
por: Bayraktar, Recep, et al.
Publicado: (2016)

Ehrlichia chaffeensis TRP120-mediated ubiquitination and proteasomal degradation of tumor suppressor FBW7 increases oncoprotein stability and promotes infection
por: Wang, Jennifer Y., et al.
Publicado: (2020)

Isolated Erythrocytosis Associated With 3 Novel Missense Mutations in the EGLN1 Gene
por: Moore, Joseph A., et al.
Publicado: (2020)

Genetic Analysis of EGLN1 C127S Variant in Taiwanese Parkinson's Disease
por: Chiang, Han-Lin, et al.
Publicado: (2020)

Genome-Wide Knockout Screen Identifies EGLN3 Involving in Ammonia Neurotoxicity
por: Li, Jiequn, et al.
Publicado: (2022)

Association between an indel polymorphism within the distal promoter of EGLN2 and cancer risk: An updated meta‐analysis
por: Zhang, Shulong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r0bc8suhqjd8pph9ttq1ifqgeb